Lower Incidence of Severe Damage to Target Organs in Mexican Patients With Systemic Sclerosis and Diffuse Skin Affection

Medsger, 2002, Systemic sclerosis (scleroderma): clinical aspects, 1590 Steen, 2000, Severe organ involvement in systemic sclerosis with diffuse scleroderma, Arthritis Rheum, 43, 2437, 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U Laing, 1997, Racial differences in scleroderma among women in Michigan, Arthritis Rheum, 40, 734, 10.1002/art.1780400421 Reveille, 2001, Systemic sclerosis in 3 US ethnic groups: a comparison of clinical sociodemographic, serologic, and immunogenic determinants, Semin Arth Rheum, 30, 332, 10.1053/sarh.2001.20268 Steen, 1994, Severe restrictive lung disease in systemic sclerosis, Arthritis Rheum, 37, 1283, 10.1002/art.1780370903 Kuwana, 1999, Influence of ethnic background on clinical and serological features in patients with systemic slcerodid and anti-DNA topoisomerase I antibody, Arthritis Rheum, 42, 465, 10.1002/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y 1980, Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum, 23, 581, 10.1002/art.1780230510 LeRoy, 1988, Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis, J Rheumatol, 15, 202 Steen, 1982, D-penicillamine therapy in progressive systemic sclerosis (scleroderma), Ann Intern Med, 97, 652, 10.7326/0003-4819-97-5-652 Clements, 1999, High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two year, double blind, randomized, controlled clinical trial, Arthritis Rheum, 42, 1194, 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7 Taskhin, 2006, Cyclophosphamide versus placebo in scleroderma lung disease, N Engl J Med, 354, 2655, 10.1056/NEJMoa055120 McNeilage, 1989, Racial differences in antinuclear antibody patterns and clincal manifestations of scleroderma, Arthritis Rheum, 32, 54, 10.1002/anr.1780320109 Reveille, 1992, Racial differences in the frequencies of scleroderma related autoantibodies, Arthritis Rheum, 35, 216, 10.1002/art.1780350215 Niert, 2006, Racial variation in clinical and immunological manifestations of systemic sclerosis, J Rheumatol, 33, 263 Arnett, 1996, Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma Association with an Amerindian HLA haplotype, Arthritis Rheum, 39, 1362, 10.1002/art.1780390814